Integrated pharmacoanalysis, bioinformatics analysis, and experimental validation to identify the ingredients and mechanisms of Xiao-Luo-Wan in uterine fibroids treatment
The integration of mass spectrometry, network pharmacology, molecular docking and biological experiments revealed the key constituents of XLW and its pharmacological mechanism in UFs, which may help in the discovery of therapeutic agents for treating UFs.
Authors
- Liu Hong (ORCID: https://orcid.org/0000-0003-0308-5049)
- Fang Yang (ORCID: https://orcid.org/0000-0001-6966-9464)
- Haojun Zhang (ORCID: https://orcid.org/0000-0002-5993-5260)
- Yonghui Yu (ORCID: https://orcid.org/0000-0001-6438-7054)
Institutions
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- Pharmaceutical Biology
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1080/13880209.2025.2485905
- Primary Topic
- Phytochemistry and Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China